KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Share-based Compensation (2016 - 2025)

Evolent Health has reported Share-based Compensation over the past 11 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.4 million for Q4 2025, up 139.18% from a year ago — trailing twelve months through Dec 2025 was $39.7 million (changed 0.02% YoY), and the annual figure for FY2025 was $39.7 million, changed 0.02%.
  • Share-based Compensation for Q4 2025 was $2.4 million at Evolent Health, down from $14.7 million in the prior quarter.
  • Over the last five years, Share-based Compensation for EVH hit a ceiling of $18.8 million in Q1 2024 and a floor of -$6.1 million in Q4 2024.
  • Median Share-based Compensation over the past 5 years was $9.6 million (2023), compared with a mean of $8.5 million.
  • Biggest five-year swings in Share-based Compensation: surged 195.16% in 2022 and later crashed 157.67% in 2024.
  • Evolent Health's Share-based Compensation stood at $5.0 million in 2021, then soared by 195.16% to $14.6 million in 2022, then decreased by 27.53% to $10.6 million in 2023, then crashed by 157.67% to -$6.1 million in 2024, then soared by 139.18% to $2.4 million in 2025.
  • The last three reported values for Share-based Compensation were $2.4 million (Q4 2025), $14.7 million (Q3 2025), and $11.6 million (Q2 2025) per Business Quant data.